| Abstract | The high prevalence of inflammatory rheumatic diseases in women of childbearing age increases the risk of exposure to antirheumatic agents during conception pregnancy and breast feeding. The decision for pharmacological treatment initiation maintenance should be the result between the severity of maternal disease and the risk benefits with treatment. The aim of this paper was to review recent literature about drug fetal safety profile strength the importance of monitoring the pregnancy in patients with inflammatory rheumatic diseases and stress the need for further research in this area. |
| Authors | Sandra Falcão, Ana Filipa Mourão, J Bravo Pimentão, Jaime C Branco
(Affiliation: Serviço de Reumatologia, Centro Hospitalar de Lisboa Ocidental, EPE, Hospital Egas Moniz. sfalcao76 at gmail.com)
|
| Journal | Acta reumatológica portuguesa
(Acta Reumatol Port)
2007 Oct-Dec
Vol. 32
Issue 4
Pg. 323-31
ISSN: 0303-464X Portugal |
| Vernacular Title | Perfil de Seguranca Fetal dos Principais Grupos Farmacologicos Utilizados no Tratamento das Doencas Reumaticas Inflamatorias. |
| PMID | 18159198
(Publication Type: English Abstract, Journal Article, Review)
|
| Chemical References |
|
| Topics |
- Antirheumatic Agents
(adverse effects, pharmacology, therapeutic use)
- Female
- Fetus
(drug effects)
- Humans
- Pregnancy
- Pregnancy Complications
(drug therapy)
- Rheumatic Diseases
(drug therapy)
|
